340 W. State Street
Athens, OH 45701
Our Startup Stories Series continues with guest Dr. John Kopchick, world-renowned molecular biologist, on his 'bench to bedside' journey from basic discovery to FDA approval of the drug SOMAVERT. Since SOMAVERT hit the market in 2003, OU has received over $75M in royalty income. Come hear the true and unfiltered story as only Dr. Kopchick can tell.